Literature DB >> 11073356

Limb-girdle muscular dystrophy: one gene with different phenotypes, one phenotype with different genes.

M Zatz1, M Vainzof, M R Passos-Bueno.   

Abstract

Among 14 limb-girdle muscular dystrophy genes that have been mapped, 10 (three autosomal dominant and seven autosomal recessive) have so far had their product identified. This review will focus on the most recent data in the field and on our own experience of more than 200 patients studied with autosomal recessive-limb-girdle muscular dystrophy, classified from calpainopathy to telethoninopathy. Genotype: phenotype correlations in this highly heterogeneous group show a similar clinical course among patients with different forms, whereas a discordant phenotype may be seen in unrelated patients or in affected sibs carrying the same mutation. Understanding such similarities or differences remains a major challenge. It will depend on future knowledge of gene-protein functions, on protein interactions and on identifying modifying genes and other factors underlying clinical variability.

Entities:  

Mesh:

Year:  2000        PMID: 11073356     DOI: 10.1097/00019052-200010000-00002

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  18 in total

1.  A study of FHL1, BAG3, MATR3, PTRF and TCAP in Australian muscular dystrophy patients.

Authors:  Leigh B Waddell; Jenny Tran; Xi F Zheng; Carsten G Bönnemann; Ying Hu; Frances J Evesson; Monkol Lek; Susan Arbuckle; Min-Xia Wang; Robert L Smith; Kathryn N North; Nigel F Clarke
Journal:  Neuromuscul Disord       Date:  2011-06-17       Impact factor: 4.296

2.  A new evidence for the maintenance of the sarcoglycan complex in muscle sarcolemma in spite of the primary absence of delta-SG protein.

Authors:  Telma L F Gouveia; Patrícia M Kossugue; Julia F Paim; Mayana Zatz; Louise V B Anderson; Vincenzo Nigro; Mariz Vainzof
Journal:  J Mol Med (Berl)       Date:  2007-01-30       Impact factor: 4.599

3.  Clinical and pathological characteristics of four Korean patients with limb-girdle muscular dystrophy type 2B.

Authors:  Seung-Hun Oh; Seong-Woong Kang; Jin-Goo Lee; Sang-Jun Na; Tai-Seung Kim; Young-Chul Choi
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

Review 4.  [Limb girdle muscular dystrophies].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2004-12       Impact factor: 1.214

5.  The effect of calpain 3 deficiency on the pattern of muscle degeneration in the earliest stages of LGMD2A.

Authors:  M Vainzof; F de Paula; A M Tsanaclis; M Zatz
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

6.  A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis.

Authors:  Agnes L Nishimura; Miguel Mitne-Neto; Helga C A Silva; Antônio Richieri-Costa; Susan Middleton; Duilio Cascio; Fernando Kok; João R M Oliveira; Tom Gillingwater; Jeanette Webb; Paul Skehel; Mayana Zatz
Journal:  Am J Hum Genet       Date:  2004-09-15       Impact factor: 11.025

7.  Does delta-sarcoglycan-associated autosomal-dominant cardiomyopathy exist?

Authors:  Ralf Bauer; Judith Hudson; Harald D Müller; Clemens Sommer; Gabriele Dekomien; John Bourke; Daniel Routledge; Kate Bushby; Jörg Klepper; Volker Straub
Journal:  Eur J Hum Genet       Date:  2009-03-04       Impact factor: 4.246

8.  Calpainopathy: how broad is the spectrum of clinical variability?

Authors:  Alessandra Starling; Flavia de Paula; Helga Silva; Mariz Vainzof; Mayana Zatz
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

9.  Calpain-3 mutations in Turkey.

Authors:  Burcu Balci; Stefania Aurino; Göknur Haliloglu; Beril Talim; Sevim Erdem; Zuhal Akcören; Ersin Tan; Melda Caglar; Isabelle Richard; Vincenzo Nigro; Haluk Topaloglu; Pervin Dincer
Journal:  Eur J Pediatr       Date:  2006-01-13       Impact factor: 3.183

10.  Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression.

Authors:  Marina Fanin; Anna Chiara Nascimbeni; Luigi Fulizio; Carlo Pietro Trevisan; Marija Meznaric-Petrusa; Corrado Angelini
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.